Background The cumulative exposition to biologics is increasing with prolonged treatment with a certain biologic or consecutive biological treatment. However, long-term safety data are limited available.
Objectives The aim of this study was to prospectively evaluate the 5-year safety of biological treatment for psoriasis in daily practice.
Methods A cohort of 173 psoriasis patients on biologics was prospectively followed for 5 years. All adverse events reported were documented and analysed. Primary endpoint was the percentage of patients reporting at least one serious adverse event. The rate of malignancies, serious infections and serious cardiovascular ...
Safety of treatment with biologics for psoriasis in daily practice: 5-year data is a post from: Skincare
Safety of treatment with biologics for psoriasis in daily practice: 5-year data via BuzzBlazer.com
No comments:
Post a Comment